INTRODUCTION
During very early development, many proteins required to drive cell cycle progression and specify axis formation and body patterning are translated from maternally inherited mRNAs because transcription is mostly silent and does not resume until after the first few rounds of embryonic cell division (Johnstone and Lasko, 2001; Kuersten and Goodwin, 2003) . Hence, translational control is an intuitively important topic for developmental biologists. Several regulatory mechanisms have been characterized with molecular details, and, in many cases, they determine not only when but also where to produce specific proteins (Huang and Richter, 2004; Kindler et al., 2005; Besse and Ephrussi, 2008) . Cells use various strategies to accomplish this task, and one strategy is local control of protein synthesis-that is, selected mRNAs in a quiescent state are transported and localized to sites where their translation is initiated by specific signaling. RNA-binding proteins (RBPs) play indispensable roles in this process because they determine the identity of the transcripts to be transported and regulated.
that support the functional changes of synapses and which molecular mechanisms precisely concentrate these proteins at stimulated synapses to achieve inputspecific modifications (Liu-Yesucevitz et al., 2011; Glock et al., 2017) . In the developing nervous system, axons often travel significant distances to their target neurons for circuit wiring. The steering growth cone at the tip of the axon needs to respond rapidly to extracellular guidance cues and then precisely direct navigation (Tessier-Lavigne and Goodman, 1996; Lowery and Van Vactor, 2009) . A local translation strategy is also employed here to overcome the longdistance dispatch of proteins made in the soma. For example, netrin-1 triggers asymmetric β-actin mRNA translation before growth-cone turning (Leung et al., 2006; Yao et al., 2006) and cytoplasmic polyadenylation element-binding protein 1 (CPEB1) activates the translation of EphA2 receptor in commissural axons to direct a new trajectory route after crossing the midline (Brittis et al., 2002) . Local translation occurs even before neuronal differentiation. Radial glial cells are neural stem cells in the neuroepithelium of the developing brain used to generate cortical neurons, whose basal processes extend hundreds of micrometers to form an endfoot structure and are important for neuronal migration. A recent study showed that isolated endfeet contain fragile mental retardation protein (FMRP), which regulates the transport and translation of a local transcriptome (Pilaz et al., 2016) .
Translational Control in Autism Spectrum Disorders
Translational control, particularly on-site in growth cones and synapses, is central for axonal pathfinding and synaptic plasticity (Jung et al., 2014; Glock et al., 2017; Van Driesche and Martin, 2018) . Thus, genetic mutations resulting in aberrant translation have been identified in neurodevelopmental diseases (Scheper et al., 2007; Wang et al., 2016) , such as autism spectrum disorder (ASD), intellectual disability, and infantile epilepsy. The Simons Foundation Autism Research Initiative (SFARI) database (https:// gene.sfari.org/) lists ~1,000 genes linked to ASD. Although ASD features high heterogeneity, ASD individuals generally share core symptoms of repetitive behaviors and impaired social interaction (Belmonte et al., 2004; Rubenstein, 2011; Hoischen et al., 2014) . Defective axonal projection and synaptic function have been identified in ASD individuals and mouse models to account for the aberrant brain connectivity and behaviors (Jamain et al., 2003; Cline, 2005; Schmid and Maness, 2008; Bourgeron, 2015; Huang and Hsueh, 2015) . Many ASD genes encode proteins such as scaffold proteins, neurotransmitter receptors, and ion channels, which obviously affect synaptic function and connectivity. In addition, the list of genes contains molecules involved in translational regulation. In particular, many noteworthy findings from FMRP-related studies have derived a hypothesis that an imbalanced and dysregulated translation contributes to the ASD etiology (Richter et al., 2015) . For example, several experimentally validated FMRP-regulated mRNAs are transcribed from ASDrisk genes, such as CAMKIIA, RAC1, DLG4, MAP2, GABRB1, NLGN2, and CTNNB1 (Pasciuto and Bagni, 2014) , which encode proteins essential for synaptic signaling, structure, and function. Because ASD genes control multiple levels of neuronal development and circuit wiring, homeostatic regulation of their expressions is critically important. In contrast to FMRP, many SFARI genes that encode proteins functioning in translation have not yet been studied for their roles in neuronal development and ASD pathogenesis. Hence, in this review, we discuss SFARI genes with a possible role in neuronal translation.
Brief Overview of Translation
Eukaryotic mRNAs feature a 7-methylguanosine (m 7 GpppN) cap and poly(A) tail, both important for their stability and translation. Translation proceeds in three phases: initiation, elongation, and termination. Cap-dependent initiation is a multi-step assembly of eukaryotic initiation factors (eIFs) and scanning until the 80S ribosome is situated at the beginning of the open reading frame (ORF). EIF4F, which contains the cap-binding protein eIF4E, scaffold molecule eIF4G, and RNA helicase eIF4A at the 5′-end of mRNA, recruits the 43S pre-initiation complex, including eIF1, eIF3, eIF5, the ternary complex eIF2-GTP-MettRNAi, and 40S ribosome, together scanning along the 5′-untranslated region (UTR) to search usually for the first AUG (Fig. 1) . Subsequent hydrolysis of the eIF2-bound GTP triggers the release of eIFs and the recruitment of 60S ribosome to form a translationcompetent 80S ribosome. Translation initiation can be controlled at any one of these steps, most found at the eIF4E-eIF4G interface. Alternatively, some mRNAs also possess an internal ribosome entry site (IRES) in the 5′-UTR that bypasses eIF4E-dependent cap recognition to initiate translation. Thus, IRESharboring transcripts can be preferentially translated when eIF4E is limited. IRES is usually a structural RNA element bound by auxiliary trans-acting factors (ITAFs) to recruit the 43S complex (Fig. 1) . Recent epitranscriptome studies have found that the 5′-UTRs of some transcripts feature N 6 -methyladenosine (m 6 A)
Developmental Neurobiology modification (Huang and Lu, 2018) . For m 6 A-containing Hsp70 mRNA, once exported to the cytoplasm, the m 6 A in its 5′-UTR can be recognized by eIF3, thereby recruiting the eIF3-40S ribosome complex to initiate translation independent of cap and eIF4E (Meyer et al., 2015) . Thus, a modified m 6 A nucleotide serves as an IRES for translation when cap-mediated initiation is inhibited under heat shock stress (Fig. 1) .
Translation elongation decodes the ORF by repetitive and coordinated actions of the 80S ribosome, aminoacyl-charged tRNAs, and eukaryotic elongation factors (eEFs), eEF1 and 2, to synthesize a polypeptide until reaching a stop codon. With no specific control at this stage, the peptide synthesis rate is estimated at ~10 amino acid incorporation per second in Escherichia coli and Saccharomyces cerevisiae (Gausing, 1972; Lacroute, 1973; Boehlke and Friesen, 1975) or at ~5.6 amino acid in mouse embryonic stem cells (Ingolia et al., 2011) . Nevertheless, epitranscriptomic modifications and codon-biased amino acid incorporation suggest that the elongation rate varies in individual transcripts (Huang and Lu, 2018) . Moreover, trans-acting RBPs, including heterogeneous nuclear ribonucleoprotein (hnRNP) E1 and CPEB2, could affect the translation elongation of target-specific mRNAs via interfering with eEF1A1 and eEF2, respectively (Hussey et al., 2011; Chen and Huang, 2012) .
Translation ceases at the final termination stage. When a translocating ribosome reaches a stop codon, the tRNA-mimicking eukaryotic release factor 1 (eRF1) recognizes the stop codon and binds to the same place in the ribosome where tRNA is located to arrest the 80S ribosome. Along with the binding of eRF3 and GTP hydrolysis, they prompt the release of the polypeptide chain and the disassembly of the entire ribosome-mRNA complex to complete one round of translation (Merrick and Nyborg, 2000; Mathews et al., 2007; Pestova et al., 2007) . In view of the principle of general translation, we focus on the ASD genes encoding proteins that participate in or interfere with this process, including all RBPs and upstream signaling. and GTP form a ternary complex to associate with the 40S ribosomal subunit, followed by the recruitment of eIF1, 1A, 3, and 5 initiation factors to assemble the 43S pre-initiation complex. This complex binds to the mRNA via its interaction with the cap-binding eIF4F complex, consisting of eIF4E, 4G, and 4A, and begins scanning for the first AUG codon. In the IRES-dependent translation initiation, a highly structured RNA element in the 5′-UTR is bound by the IRES-associated trans-acting factors (ITAFs), which then recruit the 43S pre-initiation complex to start scanning. Alternatively, m 6 A in the 5′-UTR can be recognized by eIF3 to directly recruit the 43S pre-initiation complex to initiate translation. [Colour figure can be viewed at wileyonlinelibrary.com] Developmental Neurobiology
SFARI Group I Genes: General Translation Components and Their Regulators
This group contains genes encoding eIF4E, eIF3g, eEF1A2, RPL10, eIF4EBP2, and UPF3B, which participate in three different stages of translation (Fig. 2) . Because the eIF4E-eIF4G interaction is necessary for cap-dependent initiation, its disruption blocks protein synthesis at the very beginning. EIF4EBP2 is one of three eIF4E-binding proteins (4E-BPs) that competes with eIF4G for binding to the same domain of eIF4E (Bhat et al., 2015) . Most ASD mutations in the upstream promoter or intronic non-coding regions of EIF4E likely result in elevated eIF4E expression because eIF4E-transgenic mice and 4EBP2-knockout (KO) mice with exaggerated cap-dependent translation show aberrant synaptic transmission and autistic-like behaviors (Gkogkas et al., 2013; Santini et al., 2013) . So far, no human mutations have been found in EIF4EBP2. EIF3 is a complex of 13 subunits (from eIF3a to eIF3m) (des Georges et al., 2015) , but not all of the subunits, including eIF3g, are indispensable for the scanning of the 43S initiation complex to locate AUG in vitro. Moreover, knockdown of eIF3g does not affect global protein synthesis in HeLa cells (Cuchalova et al., 2010) . Although eIF3g is not a central component for the initial scanning process, it is required for the reinitiation of the post-termination ribosomes in transcripts harboring one or more short upstream ORFs (uORFs) (Herrmannova et al., 2012; Simonetti et al., 2016) . After termination in the uORF, the dissociation of the 60S subunit permits the 40S ribosome, if remaining on the 5′-UTR, to form a new ternary initiation complex and resume 3′-end scanning for the next AUG. In general, the main ORF in uORF-containing mRNAs is not translated efficiently until under a stress condition whereby the initiation process is hampered by the deficiency of eIF2-GTP-Met-tRNAi, so the 43S complex continues to scan and locate downstream AUG in the main ORF (Hinnebusch, 1993) . Hence, the purpose of reinitiation is a regulated process for protein expression, so mutations in eIF3g likely affect the translation of a subset of mRNAs.
Several missense mutations identified in eEF1A2 are associated with early infantile epileptic encephalopathy and intellectual disability (de Ligt et al., 2012; Nakajima et al., 2015) . EEF1A2 is the alpha subunit of eEF1, which recruits aminoacyl-tRNA to the ribosome upon binding to GTP. Correct codonanticodon recognition triggers GTP hydrolysis and the subsequent release of GDP-bound eEF1A from the ribosome (Crepin et al., 2014) . Unlike the ubiquitous distribution of eEF1A1, eEF1A2 is expressed in selective tissues such as muscles and brains (Chambers et al., 1998) , so its deficiency results in abnormal neurologic and muscle functions. The human ribosome (80S) is a 4.3-MDa complex composed of the 40S small subunit (18S rRNA and 33 PRSs) and the 60S large subunit (28S, 5S and 5.8S rRNAs and 47 RPLs including RPL10) (Khatter et al., 2015) . Recent studies demonstrated that ribosomes are no longer a decoding machinery of static identical components. Some RPLs and RPSs exhibit differential expression patterns across tissues and developmental periods and tissues (Shi and Barna, 2015) . Genome-wide analyses of transcripts Figure 2 Group I SFARI genes regulate different phases of translation. In addition to eIF4E, eIF3G, and 4EBP2 that regulate protein synthesis at the beginning, eEF1A2 and RPL10, as respective components of eEF1 and the 60S ribosome, control the process of peptide elongation. UPF3B slows down translation termination by binding to eRF3 and then promotes the disassembly of post-termination ribosome after eRF3-triggered GTP hydrolysis and peptide release. [Colour figure can be viewed at wileyonlinelibrary.com] Developmental Neurobiology associated with the subunit-defined ribosomes in yeast (Ferretti et al., 2017) and mouse embryonic stem cells indicate that specialized ribosomes preferentially translate different subsets of mRNAs. Nevertheless, RPL10 is located in the core of the ribosome and drives ribosomal rotation for peptide translocation, so it is indispensable for translation-proficient ribosomes (Sulima et al., 2014) . RPL10 is an X-linked gene. The two human mutations L206M and H213Q, at the C-terminus of RPL10, result in a reduced number of assembled polysomes and decreased functional complementation in a temperature-sensitive Rpl10 mutant yeast (Klauck et al., 2006; Chiocchetti et al., 2011; Sulima et al., 2014) . Whether various ASD-associated mutations in RPL10 impair its rotational equilibrium to affect translation in mice remains to be investigated.
Up-frameshift protein 3B (UPF3B) was first identified as a key component involved in non-sense-mediated RNA decay (NMD), a cellular surveillance system used to degrade mRNAs carrying a premature stop codon after the first round of translation, thereby preventing the further accumulation of truncated proteins (Isken and Maquat, 2007) . A recent study using an in vitro reconstituted system and biochemical interaction assays showed that UPF3B directly binds to eRF3, delays translation termination, and promotes the disassembly of the post-termination ribosome after eRF3-triggered GTP hydrolysis and peptide release (Neu-Yilik et al., 2017) . UPF3B is encoded by an X-linked gene. Missense and pre-terminated mutations identified in this gene are associated with schizophrenia, attention deficit hyperactivity disorder, intellectual disability, and ASD (Laumonnier et al., 2010; Addington et al., 2011) .
SFARI Group II Genes: Translational Control by miRNA-Induced Silencing Complex
MiRNAs, a conserved class of small RNAs of about 20-22 nt in length, regulate the expression of their target mRNAs via the miRNA-induced silencing complex (miRISC) (Ameres and Zamore, 2013; Ha and Kim, 2014) , which recognizes the mRNA targets by base-pairing to partially complementary sequences in the 3′-UTR. The family of trinucleotide repeat-containing 6 proteins (TNRC6A; also known as GW182), TNRC6B and TNRC6C, plays an essential role in miRNA-mediated gene silencing (Huntzinger and Izaurralde, 2011; Fabian and Sonenberg, 2012) . GW182 was named because of its molecular weight and the presence of glycine and tryptophan repeats (Eystathioy et al., 2002) . TNRC6 anchors to miRISC by binding to an argonaute protein (AGO1, 2, 3, or 4) and recruits additional effectors via its C-terminal silencing domain (SD) to downregulate gene expression (Fig. 3) . The SD is a bipartite region composed of the middle and C-terminal GW-rich regions. The SD associates with the cytoplasmic poly(A)-binding protein (PABPC1), thereby interfering with the PABPC1-eIF4G interaction. It Figure 3 Group II SFARI genes control translation by miRNA-induced silencing complex. A single-strand miRNA associated with an AGO protein in the miRNA-induced silencing complexes (miRISC) recognizes target mRNAs by base pairing to complementary sequences in their 3ʹ-UTR. TNRC6/GW182 binds to an AGO protein and exerts its repression activity via the C-terminal silencing domain in two ways. GW182 interacts with cytoplasmic poly(A)-binding protein 1 (PABPC1) to interfere in the eIF4G-PABPC1 association, thereby impairing the assembly of the eIF4F complex at the 5′-end of mRNA. It also interacts with the cytoplasmic deadenylase complexes PAN2-PAN3 and CCR4-NOT, which promote deadenylation-induced RNA degradation. [Colour figure can be viewed at wileyonlinelibrary.com] Developmental Neurobiology also binds to the deadenylase complexes, CCR4-NOT, and PAN2-PAN3, which promote deadenylation-induced mRNA decay (Jonas and Izaurralde, 2015) . GW182 was initially identified as an autoimmune antigen in patients with motor and sensory polyneuropathy and exhibited cytoplasmic speckle distribution (Eystathioy et al., 2002) . These speckle structures, named GW-bodies, later coincide with the processing-bodies (P-bodies) that are the sites for RNA processing. In this complex machinery, AGO1, TNRC6B, and CNOT3 carrying missense or truncated mutations are associated with ASD. AGO1-KO mice are viable (Van Stry et al., 2012) , but mice lacking CNOT3 (Morita et al., 2011) or TNRC6B die, mostly if not all at the embryonic or early postnatal stage, respectively. So far, no behavior study has been conducted in Ago1 +/− , Tnrc6b +/− , or Cnot3 +/− mice. Genome-wide miRNA expression profiling in serum and postmortem brains from ASD individuals indicates that miRNAs and co-regulated modules are perturbed in ASD (Banerjee-Basu et al., 2014; Mundalil Vasu et al., 2014; Takata et al., 2016; Wu et al., 2016) . Thus, dysregulated miRNA-regulated gene expression contributes to ASD etiology.
SFARI Group III Genes: Target-Specific Controls by RBPs and Their Partners
Translation of selective mRNAs can be modulated by cis-regulatory sequences that often reside in the 5′-or 3′-UTR of the mRNA and/or by their cognate RBPs. Moreover, such a control is also important to transport and localize sub-transcriptomes in the neuronal subdomains. Notably, most RBPs shuttle between nucleocytoplasmic compartments and exert multiple functions in RNA processing, including splicing, nuclear export, and decay. Here, we discuss only their (possible) functions related to RNA transport and translation.
Cell cycle-associated protein 1 (Caprin1) interacts with DEAD-box RNA helicase 3X (DDX3X), which binds to mRNAs with a structured 5′-UTR and translation initiation factors, so Caprin1 may affect translation via DDX3X (Copsey et al., 2017) . Caprin1-KO mice have impaired hippocampus-dependent synaptic plasticity and long-term memory because dendritic localization of some mRNAs is affected (Nakayama et al., 2017) . Caprin1 +/− mice with normal memory acquisition have difficulty in reversal spatial learning and exhibit autistic-like behaviors, including impaired social behaviors and reduced preference for novel objects and place patterns (Ohashi et al., 2016) . Caprin1 also co-localizes with FMRP in the polysomal fraction and in transporting RNA granules and shares some common mRNA targets with FMRP, so it may coordinate with FMRP to modulate translation and/or transport of selective mRNAs (El Fatimy et al., 2012) .
CUGBP, Elav-like family members 4 and 6 (CELF4 and 6), contains RNA recognition motifs and helps in splicing (Ladd et al., 2004; Han and Cooper, 2005) . However, CELF4 is mostly detected in the somatodendritic compartment of the neurons, and its deficiency changes the abundance, subcellular, and/or the polysomal distribution of selective mRNAs (Wagnon et al., 2012) , which suggests its potential role in regulating mRNA transport, stability, and translation. Celf4 +/− and Celf4 −/− mice show a complex seizure disorder, developed in a gene dose-sensitive manner. Electro-recording data in the layer V cortical pyramidal neurons revealed that the initiation threshold of action potential is decreased and persistent sodium current is increased due to the elevated expression of sodium channel Nav1.6 in both Celf4 +/− and Celf4
neurons (Sun et al., 2013) . Although it is not known whether CELF6 regulates other RNA processing besides splicing, CELF6-KO mice exhibit autistic-like behaviors and have abnormal serotonin level in the brain (Dougherty et al., 2013) . Drosophila embryonic-lethal abnormal vision-like protein in mammal 2 and 3 (ELAVL2 and 3), also known as HuB and HuC, belong to the ELAVL family of 4 RBPs that recognize the AU-rich elements in the 3′-UTR of target mRNAs to increase mRNA stability and/or translation (Pascale et al., 2008) . Although ELAVL1 is ubiquitously present, ELAVL2-4 are highly expressed in neurons to regulate neuronal differentiation and maturation (Colombrita et al., 2013; Ogawa et al., 2018a; 2018b) and are autoantigens causing paraneoplastic encephalomyelopathy (Okano and Darnell, 1997) . A recent study also indicated their roles in differentially transporting brain-derived neurotrophic factor (BDNF) transcripts harboring short or long 3′-UTR (Vicario et al., 2015) . Although no study has addressed social behaviors in mice with ELAVL2 or 3 deficiency, Elavl3 +/− mice have cortical hypersynchronization and Elavl3 −/− mice show progressive motor deficits leading to cerebellar ataxia (Akamatsu et al., 1999; Ince-Dunn et al., 2012) .
FMRP is the best characterized RBP in the ASD gene list, and its deficiency or mutation leads to fragile X syndrome (FXS). FMRP generally functions as a translational repressor via multiple mechanisms. First, FMRP associates with some of its target mRNAs via dendritic non-coding, brain cytoplasmic RNA 1 (BC1 RNA) to downregulate translation (Zalfa et al., 2003) . The tudor domain of FMRP is responsible for Developmental Neurobiology binding to BC1 RNA, and the interaction is weakened by 2′-O-methylation of BC1 RNA. Moreover, most BC1 RNA is not 2′-O-methylated at synapses, so the FMRP-BC1 RNA complex represses target mRNA translation most potently at the synapses (Lacoux et al., 2012) . In addition, FMRP could inhibit mRNA translation via binding to cytoplasmic FMRPinteracting protein 1 (CYFIP1), encoded by another ASD-risk gene. CYFIP1 contains an eIF4E-binding motif and functions like 4EBPs to block the eIF4E-eIF4G interaction. The FMRP-CYFIP1 interaction is enhanced by the presence of BC1 RNA. On activation of the BDNF or metabotropic glutamate receptor (mGluR) signaling, CYFIP1 dissociates from eIF4E, which leads to translational activation of target mRNAs (Napoli et al., 2008) . Several FMRP-bound mRNAs are translationally repressed at initiation, but an analysis of the transcripts co-precipitated with polyribosome-associated FMRP indicates that FMRP can reversibly stall ribosomes on selective transcripts and repress translation elongation in a reconstituted translation system (Darnell et al., 2011) . Nevertheless, the molecular mechanism of how FMRP stops ribosome translocation on mRNA is not clear. For more insights on FMRP and FXS, please refer to the previous reviews (De Rubeis et al., 2012; Santoro et al., 2012; Pasciuto and Bagni, 2014; Banerjee et al., 2018) .
Grb10-interacting GYF proteins 1 and 2 (GIGYF1 and 2), initially identified to be associated with tyrosine kinase receptors, bind to the cap-binding protein eIF4E homologous protein (4EHP) but not eIF4E. 4EHP does not interact with eIF4G, so the GIGYF-4EHP repression complex fails to initiate translation (Morita et al., 2012; Peter et al., 2017) . Moreover, GIGYF2 can also associate with the CCR4-NOT deadenylase complex to decrease mRNA stability (Peter et al., 2017; Amaya Ramirez et al., 2018) . The GIGYF2 gene is also linked to familial Parkinson's disease. Although Gigyf2 −/− mice die within 48 h after birth, Gigyf2 +/− mice grow normally and show motor dysfunction at 12-15 months of age (Giovannone et al., 2009) . No social behavior studies have been conducted in these mice.
HnRNPH2 and hnRNPU belong to the large family of hnRNPs, which control multiple aspects of RNA metabolism including splicing, stability, and translation (Geuens et al., 2016) . Although the role of hnRNPH2 and hnRNPU in mRNA transport and translation has not been reported, family members such as hnRNPE1 and hnRNPA2 are known to regulate these processes (Doyle and Kiebler, 2011; Hussey et al., 2011) .
Janus kinase and microtubule-interacting protein 1 (JAKMIP1), identified by binding to Janus kinase and microtubule, also interacts (directly or indirectly) with polyribosomes and molecules in translation, including FMRP, PABPC1, eEF1A, eEF2, and several ribosomal subunits. JAKMIP1 regulates neuronal translation with an unidentified mechanism. JAKMIP1-KO mice display social deficits, stereotypic behavior, and abnormal postnatal vocalizations (Berg et al., 2015) .
KH domain-containing, RNA-binding, signal transduction-associated 2 and 3 (KHDRBS2 and 3) are less characterized than the family member KHDRBS1 (i.e., Sam68). KHDRBS1 regulates RNA metabolism, including transcription, alternative splicing, and RNA transport (Sanchez-Jimenez and Sanchez-Margalet, 2013) .
Leucine-rich pentatricopeptide repeat-containing protein (LRPPRC) is a mitochondrial RBP regulating the stability of all 12 mitochondrial RNAs (mtRNAs) transcribed from the heavy chain of the mtDNA genome. Moreover, some mtRNAs are translated at higher levels than others, but the newly produced translation products from several mtRNAs are labile, which suggests that LRPPRC is also required to coordinate mitochondrial translation (Ruzzenente et al., 2012) . Missense mutations of this protein cause a French-Canadian type of Leigh syndrome, a neurodegenerative disorder characterized by complex IV deficiency. Lrpprc −/− mice are embryonic-lethal, but Lrpprc +/− mice have not been investigated with behavioral studies.
RNA binding protein, fox-1 homolog (RBFOX1) regulates the neuronal splicing networks involved in neurodevelopmental disorders and neuronal excitability (Gehman et al., 2011) and is itself alternatively spliced to produce nuclear and cytoplasmic isoforms. A recent study demonstrated that cytoplasmic Rbfox1 regulates the stability and translation of its target mRNAs . Although cytoplasmic Rbfox1-bound mRNAs are involved in cortical development and autism , no mouse model with specific deletion of cytoplasmic Rbfox1 is available for behavior study.
Among RNA-binding motif proteins RBM27, S3 and 8A, and RBP with serine-rich domain 1 (RNPS1), only RBM8A and RNPS1 are more characterized. RBM8A (better known as Y14) and RNPS1 are the key components of the exon-junction complex, which forms on a pre-mRNA at the junction of two joined exons after splicing and participates in several post-splicing events, including nuclear export, surveillance, localization, translation, and NMD Wiegand et al., 2003; Nott et al., 2004) . Moreover, Y14 can enhance translation of an intronless reporter mRNA by binding to the cap structure or by IRES-mediated initiation in reporter assays (Lee et al., 2009; Chuang et al., 2016) . However, how Y14 promotes both cap-dependent and independent translation remains unidentified. Y14 regulates radial glial proliferation and neuronal differentiation. Rbm8a +/− mice show defective neurogenesis and cortical lamination, which leads to severe microcephaly (Mao et al., 2015) .
Translin is also known as the testis-brain RBP (TB-RBP) and regulates mRNA transport and translation in germ cells and neurons. Translin forms a complex with translin-associated protein X (Trax); together, their endoribonuclease activity promotes RNA interference and tRNA processing (Liu et al., 2009; Ye et al., 2011; Li et al., 2012) . Translin associates with microtubules and motor proteins and directs dendritic mRNA transport. In translin-KO mice, the basal level of dendritic BDNF mRNA is decreased in the CA1 pyramidal neurons (Wu et al., 2011) and the expression of multiple brain mRNAs is altered. Translin-KO mice show abnormalities in learning and memory, anxiety-related behaviors, sensorimotor gating, and the amount of monoamine neurotransmitter in several forebrain regions, which supports the role of translin in mental retardation, attention deficit hyperactivity disorder, epilepsy, and ASD (Stein et al., 2006) . YTHDC2 belongs to the family of YTH-domain containing proteins, which recognize m 6 A modification. YTHDC2, when tethered to a reporter mRNA, decreases its abundance but enhances its translation (Hsu et al., 2017) . Unlike other YTH-domain containing proteins, YTHDC2 harbors the RNA-binding and ATPase domains with RNA helicase activity. Moreover, YTHDC2 interacts with the proteins in the NMD pathway, including the exoribonuclease XRN1 and helicases UPF1 (Wojtas et al., 2017) , so YTHDC2 may simultaneously accelerate the target mRNA degradation after translation. YTHDC2-KO mice of both sexes are infertile due to arrested germ cell development at the zygotene stage (Hsu et al., 2017; Wojtas et al., 2017) , but no study related to neuronal function has been reported.
SFARI Group IV Genes: Signaling Molecules in Controlling Translation
The signaling pathways phosphoinositide-3-kinasemammalian target of rapamycin (PI3K-mTOR) and RAS-extracellular signal-regulated kinase (RAS-ERK) regulate the phosphorylation status of several translation components, such as eIF4E, 4E-BP, eIF4B, eEF2, and RPS6, to influence protein synthesis. PI3K, catalytic subunit γ and regulatory subunit 2β (PIK3CG and PIK3R2), phosphatase and tensin homolog (PTEN), tuberous sclerosis 1 and 2 (TSC1 and 2), and mTOR are in the PI3K-mTOR pathway. Mitogen-activated protein kinases 1 and 3 (MAPK1 and 3; also known as ERK2 and ERK1, respectively), ribosomal protein S6 kinase, 90kDa, and polypeptides 2 and 3 (RPS6KA2 and 3) are in the RAS-ERK pathway. Both signaling pathways upregulate global protein synthesis, so translational imbalance contributes in part to the etiopathogenesis of ASD. We refer to several excellent reviews that discuss both the pathways in detail (Holz et al., 2005; Sonenberg and Hinnebusch, 2009; Mendoza et al., 2011; Borrie et al., 2017; Hagerman et al., 2017) .
Dual-specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A), located in the Down syndrome critical region of chromosome 21, is linked to the manifestation of Down syndrome phenotypes when triplicated. Haploinsufficiency of DYRK1A causes microcephaly in mice and humans. Several missense and indel mutations in DYRK1A were identified in ASD individuals. DYRK1A phosphorylates many important substrates, including the ε subunit of eIF2B, which is the guanine nucleotide exchange factor converting eIF2 from the GDP-bound to GTPbound form. Phosphorylation of eIF2Bε at Ser539 by DYRK1A primes subsequent Ser535 phosphorylation by glycogen synthase kinase 3 to inhibit eIF2B function and thus downregulates translation (Welsh et al., 1998; Woods et al., 2001 ).
Correction of Imbalanced Translation for Treating ASD
Intervention of dysregulated translation in ASD mouse models has successfully mitigated autistic phenotypes. The mechanism-based approach was first used to treat FXS mice (i.e., Fmr −/y mice). FMRP mostly functions as a translational repressor signaling through mGluRs to regulate synaptic proteomes and plasticity. For example, mGluR and protein synthesis-dependent long-term depression in Fmr −/y hippocampi are abnormally enhanced because of an elevated protein expression. Genetic or pharmacological downregulation of mGluR signaling mitigates autistic behaviors in Fmr −/y mice (Bear et al., 2004) . Moreover, in two ASD mouse models with exaggerated translation (i.e., eIF4E-transgenic mice and 4EBP2-KO mice), a pharmacological blockade of the eIF4E-eIF4G interaction by infusing the peptide inhibitor 4EGI-1 ameliorates cap-dependent translation and autistic behaviors (Gkogkas et al., 2013; Santini et al., 2013) . Similarly, several treatments to inhibit translation in Fmr −/y mice had beneficial effects on correcting some FXS core phenotypes. These treatments include infusion of 4EGI-1 peptide to block eIF4E-eIF4G assembly and Developmental Neurobiology administration of metformin or lovastatin to downregulate RAS-ERK signaling (Osterweil et al., 2013; Gantois et al., 2017; Santini et al., 2017) . Such therapeutic interventions downregulate global translation but sufficiently rescue some autism-like defects in several ASD mouse models.
Notably, excessive translation cannot be a universal outcome of all defective ASD genes discussed here. Based on their molecular actions identified, while truncated mutations in GIGYF1, GIGYF2, and TNRC6B may result in elevated translation, missense mutations in RPL10 and EEF1A2 likely impair protein synthesis. Moreover, the experimental results may surprisingly contradict the initial prediction. For example, TSC1 and TSC2 function as negative regulators upstream of mTOR signaling. Although Tsc2 +/− mice showed elevated mTOR activity and autistic behaviors similar to Fmr −/y mice, they exhibited suppressed translation and mGluR-dependent long-term depression, which are opposite to those alterations in Fmr −/y mice (Auerbach et al., 2011) . Several electrophysiological and behavioral deficits, instead of being exacerbated, are rescued in Fmr −/y Tsc2 +/− double mutant mice (Auerbach et al., 2011) . Therefore, altered translation in either direction out of an optimal range could both lead to shared developmental and behavioral abnormalities.
A serendipitous finding points to an interesting direction to understand the dysregulated translation in ASD pathogenesis. By crossing Fmr −/y mice with mice deficient in another translational regulator, CPEB1, autistic features and elevated protein synthesis were mostly normalized in Fmr −/y Cpeb1 −/− double KO mice (Udagawa et al., 2013) , which suggests that some, if not all, FMRP-repressed target mRNAs are translationally activated by CPEB1 to control brain development. The removal of the positive regulator CPEB1 can compensate for the loss of the negative regulator FMRP to rebalance the expression level of ASD-linked translatome. Because CPEB1-KO mice do not show autistic-like behaviors, specific inhibition of CPEB1 function in FXS individuals may avoid unwanted side effects caused by blocking global translation.
Many genes involved in translation are linked to ASD. A hypothesis is that mutations in these ASD genes interfere with some common and interconnected downstream pathways to affect axonal projection and synaptic formation during development and lead to mis-wired brain circuitry involved in emotion, communication, and social interaction. If true, identifying and targeting these common pathways may provide other therapeutic targets for treating ASD. Both studies in the genetic reduction of Tsc2 or ) mice may provide molecular insights to test this hypothesis. Nevertheless, translational control of any given mRNAs could vary by developmental stage and neuronal type. For example, we found that CPEB4 regulates c-FOS mRNA translation in only olfactory granule cells within postnatal two weeks, despite the co-existence of CPEB4 and c-FOS mRNA in most brain areas and developmental stages (Tseng et al., 2017) . Thus, the source of brain tissues isolated from ASD mouse models may profoundly affect the analysis and interpretation of such omics study. Despite no ASD-linked mutations in CPEB4, a recent study reported that a reduction in exon 4-containing CPEB4 transcript was found in the brains of individuals with idiopathic ASD (Parras et al., 2018) . Because CPEB4 promotes translation via increasing the polyadenylation of the target mRNAs, many transcripts with reduced poly(A)-tail length were found in ASDrisk genes, such as DYRK1A, RBFOX1, and PTEN. Moreover, transgenic mice expressing exon 4-deleted Cpeb4 transcript instead of Cpeb4 +/− and Cpeb4 −/− mice exhibited ASD-like phenotypes in neuromorphology, electrophysiology, and behavior (Parras et al., 2018) . These results suggest that altered splicing of a translational regulator CPEB4, likely triggered by environmental factors, perturbs neuronal development by affecting the expression of a group of ASD genes, thereby providing an idiopathic ASD model caused by dysregulated translation.
Conclusions and Perspectives
Regardless of the possible side effects by blocking mGluR signaling, a clinical trial of mavoglurant (i.e., an mGluR antagonist) in adolescents and adults with FXS failed to show promising therapeutic benefits (BerryKravis et al., 2016) . Because ASD is a developmental disorder and FMRP-controlled translation begins very early in progenitors and differentiating neurons (La Fata et al., 2014; Pilaz et al., 2016) , the earlier therapeutic intervention should have better outcomes. Although metformin and lovastatin are also prescribed for children with type 2 diabetes and high cholesterol, respectively, whether they are safe for repurposing use to treat FXS in toddlers (2-3 years old) needs further evaluation. Global downregulation in translation, if not properly monitored and controlled, may cause other neurodevelopmental disorders. A recent study reported a significant reduction in the rate of protein synthesis in Developmental Neurobiology olfactory neurosphere-derived cells and induced pluripotent stem cell-derived neurons from schizophrenic individuals. Proteomic and transcriptomic data from these cells suggest dysfunctional control of eIF2α, eIF4, and mTOR signaling (English et al., 2015) . Thus, the identification of the markers to assess behavioral and cognitive benefits is needed to properly adjust the pharmacological dose with long-term treatment in young ASD individuals. Alternatively, identifying mRNAs whose abnormal translation accounts for ASD etiology may help design new therapeutic strategies.
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